Published in Science on September 30, 1988
Double targeted gene replacement for creating null mutants. Proc Natl Acad Sci U S A (1991) 3.72
Cellular responses to Cisplatin-induced DNA damage. J Nucleic Acids (2010) 1.82
Systems biology of cisplatin resistance: past, present and future. Cell Death Dis (2014) 1.74
Mechanisms and insights into drug resistance in cancer. Front Pharmacol (2013) 1.70
Synergy between PPARgamma ligands and platinum-based drugs in cancer. Cancer Cell (2007) 1.60
Functional analysis of the transcription repressor PLU-1/JARID1B. Mol Cell Biol (2007) 1.57
Molecular mechanisms of drug resistance. Biochem J (1990) 1.56
Redox control of resistance to cis-diamminedichloroplatinum (II) (CDDP): protective effect of human thioredoxin against CDDP-induced cytotoxicity. J Clin Invest (1996) 1.44
Metallothionein protects DNA from oxidative damage. Biochem J (1993) 1.42
Cisplatin-resistant cells express increased levels of a factor that recognizes damaged DNA. Proc Natl Acad Sci U S A (1990) 1.39
Increased gene-specific repair of cisplatin interstrand cross-links in cisplatin-resistant human ovarian cancer cell lines. Mol Cell Biol (1992) 1.39
3-aminobenzamide and/or O6-benzylguanine evaluated as an adjuvant to temozolomide or BCNU treatment in cell lines of variable mismatch repair status and O6-alkylguanine-DNA alkyltransferase activity. Br J Cancer (1996) 1.38
Ribozyme-mediated cleavage of c-fos mRNA reduces gene expression of DNA synthesis enzymes and metallothionein. Proc Natl Acad Sci U S A (1991) 1.37
Modulation of cis-diamminedichloroplatinum(II) resistance: a review. Br J Cancer (1992) 1.25
Metallothionein expression in hepatocellular carcinoma. World J Gastroenterol (2002) 1.12
Reduced endocytosis and altered lysosome function in cisplatin-resistant cell lines. Br J Cancer (2003) 1.12
Silencing of metallothionein-I gene in mouse lymphosarcoma cells by methylation. Oncogene (1999) 1.11
Identification of semaphorin E as a non-MDR drug resistance gene of human cancers. Proc Natl Acad Sci U S A (1997) 1.10
Reduced expression of small GTPases and hypermethylation of the folate binding protein gene in cisplatin-resistant cells. Br J Cancer (2004) 1.04
Overexpressed human metallothionein IIA gene protects Chinese hamster ovary cells from killing by alkylating agents. Proc Natl Acad Sci U S A (1990) 1.01
Metallothionein expression correlates with metastatic and proliferative potential in squamous cell carcinoma of the oesophagus. Br J Cancer (1999) 0.97
In vitro platinum drug chemosensitivity of human cervical squamous cell carcinoma cell lines with intrinsic and acquired resistance to cisplatin. Br J Cancer (1993) 0.96
Metallothionein expression in human breast cancer. Br J Cancer (1995) 0.95
Differential expression of metallothionein 1 and 2 isoforms in breast cancer lines with different invasive potential: identification of a novel nonsilent metallothionein-1H mutant variant. Am J Pathol (2003) 0.94
Correlation of metallothionein expression with apoptosis in nasopharyngeal carcinoma. Br J Cancer (2000) 0.94
Mammalian metallothionein in toxicology, cancer, and cancer chemotherapy. J Biol Inorg Chem (2011) 0.94
A mutant mouse (tx) with increased hepatic metallothionein stability and accumulation. Biochem J (1993) 0.91
Pharmacogenetics research on chemotherapy resistance in colorectal cancer over the last 20 years. World J Gastroenterol (2014) 0.91
Identification by functional cloning from a retroviral cDNA library of cDNAs for ribosomal protein L36 and the 10-kDa heat shock protein that confer cisplatin resistance. Mol Pharmacol (2006) 0.90
Depletion of protein kinase C (PKC) by 12-O-tetradecanoylphorbol-13-acetate (TPA) enhances platinum drug sensitivity in human ovarian carcinoma cells. Br J Cancer (2000) 0.89
Metallothionein - immunohistochemical cancer biomarker: a meta-analysis. PLoS One (2014) 0.88
Cytoplasmic p21 is a potential predictor for cisplatin sensitivity in ovarian cancer. BMC Cancer (2011) 0.88
Molecular mechanisms of heptaplatin effective against cisplatin-resistant cancer cell lines: less involvement of metallothionein. Cancer Cell Int (2004) 0.87
Dinuclear platinum anticancer complexes with fluorescent N,N'-bis(aminoalkyl)-1,4-diaminoanthraquinones: cellular processing in two cisplatin-resistant cell lines reflects the differences in their resistance profiles. J Biol Inorg Chem (2005) 0.86
Zinc chelation: a metallothionein 2A's mechanism of action involved in osteosarcoma cell death and chemotherapy resistance. Cell Death Dis (2013) 0.86
Protein expression profiles indicative for drug resistance of non-small cell lung cancer. Br J Cancer (2002) 0.85
Genomic imbalances associated with acquired resistance to platinum analogues. Am J Pathol (1999) 0.85
Mechanisms of resistance to alkylating agents. Cytotechnology (1998) 0.84
Prognostic significance of metallothionein expression in renal cell carcinoma. World J Surg Oncol (2005) 0.84
Prognostic evaluation of metallothionein expression in human colorectal neoplasms. J Clin Pathol (1999) 0.84
Reaction of human metallothionein-3 with cisplatin and transplatin. J Biol Inorg Chem (2009) 0.84
Radiation-induced transient cisplatin resistance in murine fibrosarcoma cells associated with elevated metallothionein content. Br J Cancer (1993) 0.83
Monitoring metal ion flux in reactions of metallothionein and drug-modified metallothionein by electrospray mass spectrometry. Protein Sci (1998) 0.83
2'-deoxy-5-azacytidine increases binding of cisplatin to DNA by a mechanism independent of DNA hypomethylation. Br J Cancer (1993) 0.83
Metallothionein levels in ovarian tumours before and after chemotherapy. Br J Cancer (1991) 0.82
Chemotherapeutic drug resistance in the management of head and neck cancer. Eur Arch Otorhinolaryngol (1993) 0.81
Dinuclear platinum complexes with N, N'-bis(aminoalkyl)-1,4-diaminoanthraquinones as linking ligands. Part II. Cellular processing in A2780 cisplatin-resistant human ovarian carcinoma cells: new insights into the mechanism of resistance. J Biol Inorg Chem (2004) 0.81
Exposure of human ovarian carcinoma to cisplatin transiently sensitizes the tumor cells for liposome-mediated gene transfer. Proc Natl Acad Sci U S A (1994) 0.81
Drug resistance in lung cancer. Lung Cancer (Auckl) (2010) 0.80
Expression of metallothioneins in cutaneous squamous cell carcinoma and actinic keratosis. Pathol Oncol Res (2012) 0.80
A short update on cancer chemoresistance. Wien Med Wochenschr (2014) 0.79
MicroRNA-mRNA functional pairs for cisplatin resistance in ovarian cancer cells. Chin J Cancer (2014) 0.79
Metallothionein in bladder cancer: correlation of overexpression with poor outcome after chemotherapy. World J Urol (2007) 0.78
BCNU-sequestration by metallothioneins may contribute to resistance in a medulloblastoma cell line. Cancer Chemother Pharmacol (2008) 0.77
p22phox confers resistance to cisplatin, by blocking its entry into the nucleus. Oncotarget (2015) 0.77
Induction of drug resistance to gold sodium thiomalate in a monocyte cell line, THP-1. Clin Rheumatol (1998) 0.77
Prediction of Cancer Drug Resistance and Implications for Personalized Medicine. Front Oncol (2015) 0.77
Daunorubicin and doxorubicin but not BCNU have deleterious effects on organotypic multicellular spheroids of gliomas. Br J Cancer (1996) 0.77
ECRG2 enhances the anti-cancer effects of cisplatin in cisplatin-resistant esophageal cancer cells via upregulation of p53 and downregulation of PCNA. World J Gastroenterol (2017) 0.75
Platinum (IV)-fatty acid conjugates overcome inherently and acquired Cisplatin resistant cancer cell lines: an in-vitro study. BMC Cancer (2016) 0.75
Structural basis and dynamics of multidrug recognition in a minimal bacterial multidrug resistance system. Proc Natl Acad Sci U S A (2014) 0.75
The Platin-X series: activation, targeting, and delivery. Dalton Trans (2016) 0.75
Expression of Drug-Resistant Factor Genes in Hepatocellular Carcinoma Patients Undergoing Chemotherapy with Platinum Complex by Arterial Infusion. Pharmaceutics (2010) 0.75
Effect of trifluoperazine on Tc-99m sestamibi uptake in patients with advanced nonsmall cell lung cancer. Indian J Nucl Med (2016) 0.75
Genetic variation in metallothionein and metal-regulatory transcription factor 1 in relation to urinary cadmium, copper, and zinc. Toxicol Appl Pharmacol (2015) 0.75
Cisplatin but not BCNU inhibits urokinase-type plasminogen activator levels in human glioblastoma cell lines in vitro. Clin Exp Metastasis (1997) 0.75
The sequence of the human genome. Science (2001) 101.55
The genome sequence of Drosophila melanogaster. Science (2000) 74.32
Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science (1996) 16.04
Metallothionein. Annu Rev Biochem (1986) 8.12
Splicing and the formation of stable RNA. Cell (1979) 4.71
Daptomycin-resistant, methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis (2005) 3.90
Translation of artemether-lumefantrine treatment policy into paediatric clinical practice: an early experience from Kenya. Trop Med Int Health (2008) 3.62
Expression of the hepatitis B virus surface antigen gene in cell culture by using a simian virus 40 vector. Proc Natl Acad Sci U S A (1981) 3.38
Molecular cloning of DNA fragments produced by restriction endonucleases Sa1I and BamI. Proc Natl Acad Sci U S A (1976) 3.32
Regulation of a metallothionein-growth hormone hybrid gene in bovine papilloma virus. Proc Natl Acad Sci U S A (1983) 3.06
Development and evaluation of a multiplex PCR assay for rapid detection of toxigenic Vibrio cholerae O1 and O139. FEMS Immunol Med Microbiol (1998) 2.98
Preparation of lymphocyte-activating factor from continuous murine macrophage cell lines. Cell Immunol (1977) 2.81
Effects of revised diagnostic recommendations on malaria treatment practices across age groups in Kenya. Trop Med Int Health (2008) 2.79
Effect of transradial access on quality of life and cost of cardiac catheterization: A randomized comparison. Am Heart J (1999) 2.72
Duplicated heavy metal control sequences of the mouse metallothionein-I gene. Proc Natl Acad Sci U S A (1984) 2.69
Regulation in vivo of a cloned mammalian gene: cadmium induces the transcription of a mouse metallothionein gene in SV40 vectors. J Mol Appl Genet (1982) 2.61
Partial purification of human lymphocyte-activating factor (LAF) by ultrafiltration and electrophoretic techniques. J Immunol (1977) 2.58
Oxymetry deep in tissues with low-frequency electron paramagnetic resonance. Proc Natl Acad Sci U S A (1994) 2.53
Bcl2 is the guardian of microtubule integrity. Cancer Res (1997) 2.51
Living donor renal transplantation using alemtuzumab induction and tacrolimus monotherapy. Am J Transplant (2006) 2.48
SV40 recombinants carrying rabbit beta-globin gene coding sequences. Cell (1979) 2.35
High-throughput SNP genotyping by allele-specific PCR with universal energy-transfer-labeled primers. Genome Res (2001) 2.35
Expression of the chromosomal mouse Beta maj-globin gene cloned in SV40. Nature (1979) 2.29
Tandemly duplicated upstream control sequences mediate copper-induced transcription of the Saccharomyces cerevisiae copper-metallothionein gene. Mol Cell Biol (1986) 2.28
Temporal shifts in traits of Vibrio cholerae strains isolated from hospitalized patients in Calcutta: a 3-year (1993 to 1995) analysis. J Clin Microbiol (1996) 2.21
Population and familial association between the D4 dopamine receptor gene and measures of Novelty Seeking. Nat Genet (1996) 2.18
Function and autoregulation of yeast copperthionein. Science (1985) 2.17
Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus. J Clin Endocrinol Metab (2000) 2.15
A critical appraisal of methods to grade transplant glomerulitis in renal allograft biopsies. Am J Transplant (2010) 2.14
A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy. J Clin Oncol (1992) 2.10
Yeast metallothionein. Sequence and metal-binding properties. J Biol Chem (1985) 2.09
Comparison of cloned mouse alpha- and beta-globin genes: conservation of intervening sequence locations and extragenic homology. Proc Natl Acad Sci U S A (1978) 2.03
Alterations in pulmonary mRNA encoding procollagens, fibronectin and transforming growth factor-beta precede bleomycin-induced pulmonary fibrosis in mice. J Pharmacol Exp Ther (1988) 2.01
SV40 recombinants carrying a functional RNA splice junction and polyadenylation site from the chromosomal mouse beta maj globin gene. Cell (1979) 1.98
Molecular analysis of non-O1, non-O139 Vibrio cholerae associated with an unusual upsurge in the incidence of cholera-like disease in Calcutta, India. J Clin Microbiol (1998) 1.94
Classification of antineoplastic agents by their selective toxicities toward oxygenated and hypoxic tumor cells. Cancer Res (1981) 1.91
SPARC deficiency leads to early-onset cataractogenesis. Invest Ophthalmol Vis Sci (1998) 1.83
Competition for cellular factors that activate metallothionein gene transcription. Nature (1985) 1.76
A genetic association for cigarette smoking behavior. Health Psychol (1999) 1.69
A mouse globin gene promoter is functional in SV40. Cell (1980) 1.67
Simian virus 40 carrying an Escherichia coli suppressor gene. J Mol Biol (1977) 1.65
Inferiority of single-dose sulfadoxine-pyrimethamine intermittent preventive therapy for malaria during pregnancy among HIV-positive Zambian women. J Infect Dis (2007) 1.63
Acquired multicellular-mediated resistance to alkylating agents in cancer. Proc Natl Acad Sci U S A (1993) 1.63
Fine mapping of a mouse metallothionein gene metal response element. Mol Cell Biol (1989) 1.62
Genomic structures and population histories of linguistically distinct tribal groups of India. Hum Genet (2001) 1.53
Regulation in vitro of metallothionein gene binding factors. Science (1987) 1.50
Resurgence of Vibrio cholerae O139 Bengal with altered antibiogram in Calcutta, India. Lancet (1996) 1.49
Regular arrangement of restriction sites in Drosophila DNA. Cell (1975) 1.49
Unique organization of the CTX genetic element in Vibrio cholerae O139 strains which reemerged in Calcutta, India, in September 1996. J Clin Microbiol (1997) 1.46
Impact of lack of suppression of glucagon on glucose tolerance in humans. Am J Physiol (1999) 1.44
Health facility and health worker readiness to deliver new national treatment policy for malaria in Kenya. East Afr Med J (2008) 1.43
Retracted A phase I-II trial of cisplatin, hyperthermia and radiation in patients with locally advanced malignancies. Int J Radiat Oncol Biol Phys (1989) 1.43
Abnormal RNA splicing causes one form of alpha thalassemia. Cell (1982) 1.41
Construction and expression in vivo of an internally deleted mouse alpha-fetoprotein gene: presence of a transcribed Alu-like repeat within the first intervening sequence. Nucleic Acids Res (1982) 1.40
Serine-70 is one of the critical sites for drug-induced Bcl2 phosphorylation in cancer cells. Cancer Res (1998) 1.40
Expression of two human growth hormone genes in monkey cells infected by simian virus 40 recombinants. Proc Natl Acad Sci U S A (1981) 1.39
High dose continuous infusion of bleomycin in mice: a new model for drug-induced pulmonary fibrosis. J Pharmacol Exp Ther (1987) 1.39
Metallothionein protects against the cytotoxic and DNA-damaging effects of nitric oxide. Proc Natl Acad Sci U S A (1995) 1.37
Mediation of Cryptosporidium parvum infection in vitro by mucin-like glycoproteins defined by a neutralizing monoclonal antibody. Infect Immun (2000) 1.34
Mammalian metallothionein is functional in yeast. Science (1986) 1.31
Prevention of vaginal SHIV transmission in macaques by a live recombinant Lactobacillus. Mucosal Immunol (2011) 1.30
TRNA precursor transcribed from a mutant human gene inserted into a SV40 vector is processed incorrectly. Nature (1982) 1.30
Binding of an antagonistic monoclonal antibody to an intact and fragmented EGF-receptor polypeptide. Arch Biochem Biophys (1987) 1.29
Interaction between the serotonin transporter gene and neuroticism in cigarette smoking behavior. Mol Psychiatry (2000) 1.29
Lack of metabolism as the biochemical basis of bleomycin-induced pulmonary toxicity. Proc Natl Acad Sci U S A (1983) 1.29
Cell specificity and an effect of ras on human metallothionein gene expression. Proc Natl Acad Sci U S A (1986) 1.28
Chromosomal location of human metallothionein genes: implications for Menkes' disease. Science (1984) 1.26
Bin1 functionally interacts with Myc and inhibits cell proliferation via multiple mechanisms. Oncogene (1999) 1.24
The hypoxic tumor cell: a target for selective cancer chemotherapy. Biochem Pharmacol (1980) 1.24
Characterization of a human squamous carcinoma cell line resistant to cis-diamminedichloroplatinum(II). Cancer Res (1987) 1.23
Molecular epidemiology of reemergent Vibrio cholerae O139 Bengal in India. J Clin Microbiol (1998) 1.22
Measurement of differences in pO2 in response to perfluorocarbon/carbogen in FSa and NFSa murine fibrosarcomas with low-frequency electron paramagnetic resonance oximetry. Radiat Res (1996) 1.21
Cloning and sequence analysis of two monkey metallothionein cDNAs. Gene (1983) 1.20
Structure and expression of two human metallothionein-I isoform genes and a related pseudogene. J Biol Chem (1985) 1.18
Apolipoprotein A-I directly interacts with amyloid precursor protein and inhibits A beta aggregation and toxicity. Biochemistry (2001) 1.18
Inhibition of ERK attenuates autophagy and potentiates tumour necrosis factor-alpha-induced cell death in MCF-7 cells. J Cell Mol Med (2008) 1.18
Diminished aqueous microviscosity of tumors in murine models measured with in vivo radiofrequency electron paramagnetic resonance. Cancer Res (1999) 1.16
Specificity and properties of MAb RS7-3G11 and the antigen defined by this pancarcinoma monoclonal antibody. Int J Cancer (1993) 1.15
Alkylating agents: in vitro studies of cross-resistance patterns in human cell lines. Cancer Res (1986) 1.15
Stable transcription complex on a class III gene in a minichromosome. Mol Cell Biol (1985) 1.13
Presence of tumor-associated antigens in epidermal growth factor receptors from different human carcinomas. Cancer Res (1987) 1.13
Impact of human immunodeficiency virus infection on Streptococcus pneumoniae colonization and seroepidemiology among Zambian women. J Infect Dis (2008) 1.13
Hyponatremia and hypoglycemia in acute Sheehan's syndrome. Gynecol Endocrinol (2002) 1.12
Multiple mechanisms confer drug resistance to mitoxantrone in the human 8226 myeloma cell line. Cancer Res (1999) 1.12
Preclinical studies of the combination of angiogenic inhibitors with cytotoxic agents. Invest New Drugs (1997) 1.12
Hepatitis C virus-related fibrosing cholestatic hepatitis in a renal transplant recipient. Indian J Gastroenterol (2007) 1.12
Enhancement by hyperthermia of the in vitro cytotoxicity of mitomycin C toward hypoxic tumor cells. Cancer Res (1981) 1.12
Calmodulin: a potential target for cancer chemotherapeutic agents. J Clin Oncol (1986) 1.11
Functional features of hepatitis C virus glycoproteins for pseudotype virus entry into mammalian cells. Virology (2000) 1.11
Microfluidic rheology of soft colloids above and below jamming. Phys Rev Lett (2010) 1.11
Role of metallothionein in carcinogenesis. Toxicol Appl Pharmacol (1994) 1.10
Preclinical studies and clinical correlation of the effect of alkylating dose. Cancer Res (1988) 1.10
Cystic fibrosis gene and protein expression during fetal lung development. Am J Respir Cell Mol Biol (1993) 1.08
Menkes' disease: abnormal metallothionein gene regulation in response to copper. Cell (1985) 1.08
Hepatic schistosomiasis. Infect Dis Clin North Am (2000) 1.07
Evidence of differential cisplatin-DNA adduct formation, removal and tolerance of DNA damage in three human lung carcinoma cell lines. Anticancer Drugs (1993) 1.07
NMR studies of the exocyclic 1,N6-ethenodeoxyadenosine adduct (epsilon dA) opposite deoxyguanosine in a DNA duplex. Epsilon dA(syn).dG(anti) pairing at the lesion site. Biochemistry (1991) 1.07
NMR studies of the exocyclic 1,N6-ethenodeoxyadenosine adduct (epsilon dA) opposite thymidine in a DNA duplex. Nonplanar alignment of epsilon dA(anti) and dT(anti) at the lesion site. Biochemistry (1991) 1.07
The isoforms of yeast cytochrome c oxidase subunit V alter the in vivo kinetic properties of the holoenzyme. J Biol Chem (1991) 1.06